Xiaoling Wu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 7
- Ubiquitin and proteasome pathways 6
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Yunning Liu (1 shared paper)Shiwei Liu (1 shared paper)Lijun Wang (1 shared paper)Li Y (1 shared paper)Jinling You (1 shared paper)Yue Cai (1 shared paper)Jiangmei Liu (1 shared paper)Alan D López (1 shared paper)
- Journals
- Aging (3 papers)Gene (2 papers)Oncology Reports (2 papers)Cell Death and Disease (2 papers)Digestive Diseases and Sciences (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Xiaoling Wu
75 papers receiving 1.5k citations
Xiaoling Wu's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 191
- Oncology 207
- Hepatology 52
- Health, Toxicology and Mutagenesis 87
- Molecular Biology 425
Countries citing papers authored by Xiaoling Wu
This map shows the geographic impact of Xiaoling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wu more than expected).
Fields of papers citing papers by Xiaoling Wu
This network shows the impact of papers produced by Xiaoling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wu. The network helps show where Xiaoling Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An integrated national mortality surveillance system for death registration and mortality surveillance, China Hit paper breakdown → | 2015 | 287 |
| 2 | 2020 | 142 | |
| 3 | 2010 | 91 | |
| 4 | 2007 | 87 | |
| 5 | 2015 | 84 | |
| 6 | 2014 | 43 | |
| 7 | 2019 | 38 | |
| 8 | 2014 | 34 | |
| 9 | 2018 | 32 | |
| 10 | 2020 | 31 | |
| 11 | Macrophage functional phenotype can be consecutively and reversibly shifted to adapt to microenvironmental changes. | 2015 | 31 |
| 12 | 2015 | 30 | |
| 13 | 2013 | 29 | |
| 14 | 2005 | 28 | |
| 15 | 2020 | 25 | |
| 16 | 2013 | 24 | |
| 17 | 2013 | 24 | |
| 18 | 2017 | 23 | |
| 19 | 2023 | 22 | |
| 20 | 2020 | 21 |
About Xiaoling Wu
Xiaoling Wu is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Oncology and Immunology, having authored 85 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (6 papers), Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Cancer Research (191 citations), Oncology (207 citations), Hepatology (52 citations), Health, Toxicology and Mutagenesis (87 citations) and Molecular Biology (425 citations). Xiaoling Wu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yunning Liu, Shiwei Liu, Lijun Wang, Li Y, Jinling You, Yue Cai, Jiangmei Liu, Alan D López, Peng Yin and Andrew Page. Their work appears in journals such as Aging, Gene, Oncology Reports, Cell Death and Disease and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.